Randomized Trial of Milk Oral Immunotherapy: Fixed Low-Dose vs Escalation to Medium-Dose

Key Points

• Fixed low-dose oral immunotherapy shows significant effectiveness in treating milk allergy, with results supporting better management.
• Participants receiving medium-dose escalation experienced improved immune responses compared to fixed low-dose groups.
• Randomized trial method utilized for direct comparison of dosing strategies in milk allergy treatment.
• Evidence highlights the need for tailored approaches in allergy management, potentially reshaping treatment protocols.